On the contrary, overexpression of HVEM gives a survival advantage to tumors that often correlates with poor prognosis and increased tumor aggressiveness in many human gastrointestinal cancers (58–62), carcinomas (63–65) and also in some hematological tumors (66). The gene discussed is TNFRSF14; the disease is carcinoma.